Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.

Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST.

Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4. Review.

PMID:
23172780
[PubMed - indexed for MEDLINE]
2.

Burden of pediatric hepatitis C.

El-Shabrawi MH, Kamal NM.

World J Gastroenterol. 2013 Nov 28;19(44):7880-8. doi: 10.3748/wjg.v19.i44.7880. Review.

PMID:
24307782
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L.

Lancet. 2011 Aug 13;378(9791):571-83. doi: 10.1016/S0140-6736(11)61097-0. Epub 2011 Jul 27. Review.

PMID:
21802134
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Global burden of disease (GBD) for hepatitis C.

Global Burden Of Hepatitis C Working Group.

J Clin Pharmacol. 2004 Jan;44(1):20-9. Review.

PMID:
14681338
[PubMed - indexed for MEDLINE]
5.

Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis.

Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, Rich JD, van den Bergh BJ, Degenhardt L.

Hepatology. 2013 Oct;58(4):1215-24. doi: 10.1002/hep.26387. Epub 2013 Aug 6. Review.

PMID:
23504650
[PubMed - indexed for MEDLINE]
6.

Global estimates of prevalence of HCV infection among injecting drug users.

Aceijas C, Rhodes T.

Int J Drug Policy. 2007 Oct;18(5):352-8. Epub 2007 Aug 7. Review.

PMID:
17854722
[PubMed - indexed for MEDLINE]
7.

Epidemiology of hepatitis C virus infection in Australia.

Dore GJ, Law M, MacDonald M, Kaldor JM.

J Clin Virol. 2003 Feb;26(2):171-84. Review.

PMID:
12600649
[PubMed - indexed for MEDLINE]
8.

Epidemiological update of hepatitis B, C and delta in Latin America.

Alvarado-Mora MV, Pinho JR.

Antivir Ther. 2013;18(3 Pt B):429-33. doi: 10.3851/IMP2595. Epub 2013 Jun 21. Review.

PMID:
23792375
[PubMed - indexed for MEDLINE]
9.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
[PubMed - indexed for MEDLINE]
10.

Low prevalence of anti-hepatitis C virus antibodies in Mexico: A systematic review.

Chiquete E, Panduro A.

Intervirology. 2007;50(1):1-8. Epub 2006 Nov 24. Review.

PMID:
17164551
[PubMed - indexed for MEDLINE]
11.

Hepatitis C virus infection in Scotland: epidemiological review and public health challenges.

Hutchinson SJ, Roy KM, Wadd S, Bird SM, Taylor A, Anderson E, Shaw L, Codere G, Goldberg DJ.

Scott Med J. 2006 May;51(2):8-15. Review.

PMID:
16722130
[PubMed - indexed for MEDLINE]
12.

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose).

Lancet. 2011 Jul 2;378(9785):31-40. doi: 10.1016/S0140-6736(11)60679-X. Epub 2011 Jun 24. Review.

PMID:
21705069
[PubMed - indexed for MEDLINE]
13.

The global burden of hepatitis C.

Lavanchy D.

Liver Int. 2009 Jan;29 Suppl 1:74-81. doi: 10.1111/j.1478-3231.2008.01934.x. Review.

PMID:
19207969
[PubMed - indexed for MEDLINE]
14.

The epidemiologic burden of hepatitis C virus infection in Latin America .

Szabo SM, Bibby M, Yuan Y, Donato BM, Jiménez-Mendez R, Castañeda-Hernández G, Rodríguez-Torres M, Levy AR.

Ann Hepatol. 2012 Sep-Oct;11(5):623-35. Review.

PMID:
22947522
[PubMed - indexed for MEDLINE]
15.

The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ.

BMC Infect Dis. 2013 Jun 24;13:288. doi: 10.1186/1471-2334-13-288. Review.

PMID:
23799878
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.

Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, Freedman G, Burstein R, Johns N, Engell RE, Flaxman A, Murray CJ, Vos T.

Lancet. 2013 Nov 9;382(9904):1564-74. doi: 10.1016/S0140-6736(13)61530-5. Epub 2013 Aug 29. Review.

PMID:
23993281
[PubMed - indexed for MEDLINE]
17.

[Prevalence of infections by hepatitis B, C, D and E viruses in Bolivia].

León P, Venegas E, Bengoechea L, Rojas E, López JA, Elola C, Echevarría JM.

Rev Panam Salud Publica. 1999 Mar;5(3):144-51. Review. Spanish.

PMID:
10355311
[PubMed - indexed for MEDLINE]
18.

Hepatitis A virus seroprevalence by age and world region, 1990 and 2005.

Jacobsen KH, Wiersma ST.

Vaccine. 2010 Sep 24;28(41):6653-7. doi: 10.1016/j.vaccine.2010.08.037. Epub 2010 Aug 17. Review.

PMID:
20723630
[PubMed - indexed for MEDLINE]
19.

Epidemiology of hepatitis C: geographic differences and temporal trends.

Wasley A, Alter MJ.

Semin Liver Dis. 2000;20(1):1-16. Review.

PMID:
10895428
[PubMed - indexed for MEDLINE]
20.

Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis.

Rossi C, Shrier I, Marshall L, Cnossen S, Schwartzman K, Klein MB, Schwarzer G, Greenaway C.

PLoS One. 2012;7(9):e44611. doi: 10.1371/journal.pone.0044611. Epub 2012 Sep 5. Review.

PMID:
22957088
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk